Synthesis of Protected Peptide Nucleic Acid Oligomers
J . Org. Chem., Vol. 64, No. 20, 1999 7287
of the oil with Et2O yielded 6 as a white solid that was dried
over P2O5 (385 mg, 95%): mp 118-120 °C; H NMR (DMSO-
slow. The combined organic phases were dried (MgSO4) and
concentrated to dryness in vacuo to provide 9 as a colorless
foam, which was crystallized from EtOAc-hexane to provide,
after drying in vacuo, white crystals (1.07 g, 96%): mp 98-
1
d6) δ (two rotamers) 9.26 (m, 0.6H), 9.02 (m, 0.4H), 8.58 (s,
1H), 8.33 (s, 0.4H), 8.32 (s, 0.6H), 7.45 (d, J ) 7.0 Hz, 2H),
7.38 (d, J ) 7.0 Hz, 2H), 7.33 (t, J ) 7.0 Hz, 1H), 5.36 (s, 1.2H),
5.21 (s, 2H), 5.16 (s, 0.8H), 4.41 (q, J ) 7.0 Hz, 1.2H), 4.36 (s,
0.8H), 4.35 (q, J ) 7.0 Hz, 0.8H), 4.01 (s, 1.2H), 3.70-3.34 (m,
4H), 1.26 (t, J ) 7.0 Hz, 1.8H), 1.20 (t, J ) 7.0 Hz, 1.2H); 13C
NMR (DMSO-d6) δ25 (190.3, 189.9), (170.8, 170.3), (167.2,
166.6), 152.4, 152.2, 151.5, 149.3, 145.2, 136.4, 128.4, 128.0,
127.9, 122.8, 66.3 (65.6, 65.3), (49.2, 47.6), (45.7, 45.4), (44.1,
43.9), (42.7, 41.9), (14.2, 14.1); FABMS m/z 516.2 [M + H]+,
514.1 [M - H]-. Anal. Calcd for C22H25N7O6S‚3/2H2O: C, 48.70;
H, 5.16; N, 18.07; S, 5.91. Found: C, 48.57; H, 4.88; N, 17.79;
S, 5.20.
1
100 °C; H NMR (DMSO-d6) δ 11.29 (s, 1H), 9.13 (m, 0.6H),
9.01 (m, 0.4H), 7.29 (s, 0.6H), 7.25 (s, 0.4H), 4.65 (s, 0.6H),
4.45 (s, 0.4H), 4.41-4.33 (m, 2H), 4.21 (s, 0.4H), 3.99 (s, 0.6H),
3.62-3.26 (m, 4H), 1.73 (s, 3H), 1.23 (m, 3H); 13C NMR
(DMSO-d6) δ25 (190.2, 189.9), (170.7, 170.4), (167.7, 167.2),
164.4, 150.9, 142.0, (108.2, 108.1), (65.6, 65.3), (49.0, 46.4),
(47.7, 47.6), (45.6, 45.2), (42.2, 41.9), (14.3, 14.2), (12.0, 11.9);
FABMS m/z 373.3 [M + H]+, 371.3 [M - H]-. Anal. Calcd for
C
14H20N4O6S‚H2O: C, 43.07; H, 5.67; N, 14.35; S, 8.21. Found:
C, 43.24; H, 5.10; N, 13.53; S, 8.09.
N-[2-(N-Dit h ia su ccin oyl)a m in oet h yl]-N-[[6-N-(b en z-
yloxyca r bon yl) a d en in -9-yl]a cetyl]glycin e (11). BSA (59
µL, 0.24 mmol, 1.5 equiv) was added to a suspension of freshly
prepared 6 (81 mg, 0.16 mmol) in CH3CN (9 mL) and the
mixture stirred for 30 min. Next, Cl(CdO)SCl (10) (14 µL, 0.18
mmol, 1.1 equiv) was added, resulting in a yellow solution;
the reaction was complete after 20 min as indicated by HPLC.
The suspension was distributed between EtOAc (10 mL) and
H2O (15 mL), and the aqueous phase was extracted with
EtOAc (5 × 15 mL). The organic layers were combined, dried
(MgSO4), and concentrated to a small volume that upon cooling
to -20 °C gave 11 as an off white solid (70 mg, 80%): mp 138-
140 °C; 1H NMR (DMSO-d6) δ (two rotamers) 8.59 (s, 1H), 8.39
(s, 0.3H), 8.27 (s, 0.7H), 7.45 (d, J ) 7.0 Hz, 2H), 7.39 (d, J )
7.0 Hz, 2H), 7.33 (t, J ) 7.0 Hz, 1H), 5.29 (s, 0.6H), 5.21 (s,
2H), 5.10 (s, 1.4H), 4.32 (s, 1.4H), 4.01 (t, J ) 6.8 Hz, 0.6H),
3.99 (s, 0.6H), 3.81 (t, J ) 5.3 Hz, 1.4H), 3.73 (t, J ) 6.8 Hz,
0.6H), 3.53 (t, J ) 5.3 Hz, 1.4H); 13C NMR (DMSO-d6) δ25
(170.9, 170.6), (169.6, 169.2), 167.9, 166.9, 152.7, 152.6, 151.9,
149.6, (145.6, 145.5), 136.8, 128.9, 128.4, 128.3, 122.9, 66.7,
(48.6, 48.2), (44.8, 44.4), (44.3, 44.2), (43.3, 42.7); FABMS m/z
546.2 [M + H]+, 544.0 [M - H]-. Anal. Calcd for C21H19N7O7S2‚
3/2H2O: C, 44.05; H, 3.87; N, 17.12; S, 11.19. Found: C, 43.76;
H, 3.46; N, 16.80; S, 10.73.
N -[2-(N -E t h oxyt h ioca r b on yl)a m in oe t h yl]-N -[[4-N -
(ben zyloxyca r bon yl)cytosin -1-yl]a cetyl]glycin e (7). Start-
ing with Boc-C(Z)-OH (2) (314 mg, 0.62 mmol), compound 7
was prepared as described for compound 6, except for the
workup. Following overnight reaction, the cloudy solution was
diluted with H2O (16 mL) and acidified to pH 2 with 12 N HCl.
The precipitate that formed immediately was collected by
filtration, washed with Et2O, and dried in vacuo over P2O5 to
yield a white solid, 7 (257 mg, 84%): mp 201-202 °C; 1H NMR
(DMSO-d6) δ (two rotamers) 9.24 (m, 0.6H), 9.15 (m, 0.4H),
7.90 (d, J ) 7.5 Hz, 0.6H), 7.87 (d, J ) 7.5 Hz, 0.4H), 7.41-
7.31 (m, 5H), 6.99 (d, J ) 7.5 Hz, 0.6H), 6.98 (d, J ) 7.5 Hz,
0.4H), 5.17 (s, 2H), 4.81 (s, 1.2H), 4.60 (s, 0.8H), 4.38 (q, J )
7.0 Hz, 1.2H), 4.35 (q, J ) 7.0 Hz, 0.8H), 4.01 (s, 0.8H), 3.94
(s, 1.2H), 3.63-3.24 (m, 4H), 1.22 (t, J ) 7.0 Hz, 1.8H), 1.20
(t, J ) 7.0 Hz, 1.2H); 13C NMR (DMSO-d6) δ25 (190.5, 190.1),
(168.1, 168.0), (167.3, 167.2), (163.5, 163.4), (155.5, 155.4),
153.6, 151.4, 136.4, 128.9, 128.6, 128.4, 94.3, 66.9, (65.9, 65.7),
(51.5, 48.7), 50.0, (46.4, 45.8), 42.5, 14.7; FABMS m/z 492.3
[M + H]+, 514.2 [M + Na]+, 490.2 [M - H]-. Anal. Calcd for
C
21H25N5O7S‚H2O: C, 49.50; H, 5.34; N, 13.74; S, 6.29. Found:
C, 49.60; H, 5.56; N, 13.94; S, 6.20.
N -[2-(N -E t h oxyt h ioca r b on yl)a m in oe t h yl]-N -[[2-N -
(ben zyloxyca r bon yl)gu a n in -9-yl]a cetyl]glycin e (8). Start-
ing with Boc-G(Z)-OH (3) (402 mg, 0.74 mmol), compound 8
was prepared as described for compound 6, except for workup.
Following overnight reaction, the cloudy solution obtained was
diluted with H2O (18 mL), and a white precipitate formed. The
resulting suspension was acidified to pH 2 with 12 N HCl,
whereupon the solid redissolved. EtOAc (20 mL) was added
to the solution, and a white precipitate formed that was
collected by filtration. The aqueous phase was extracted
further with EtOAc (3 × 20 mL), and the organic layers were
combined, dried (MgSO4), and concentrated under reduced
pressure. The white solids were combined, washed with Et2O,
and dried in vacuo over P2O5 to yield 361 mg of 8 (92%): mp
184-186 °C; 1H NMR (DMSO-d6) δ 11.67 (s, 0.45H), 11.55 (s,
0.55H), 11.36 (s, 0.45H), 11.35 (s, 0.55H), 9.22 (m, 0.55H), 9.00
(m, 0.45H), 7.81 (s, 0.55H), 7.79 (s, 0.45H), 7.43-7.34 (m, 5H),
5.24 (s, 2H), 5.11 (s, 0.9H), 4.92 (s, 1.1H), 4.43-4.31 (m, 2H),
4.33 (s, 0.9H), 4.01 (s, 1.1H), 3.68-3.37 (m, 4H), 1.25-1.18
(m, 3H); 13C NMR (DMSO-d6) δ25 (190.2, 189.9), (170.9, 170.4),
(167.2, 167.1), 150.2, (154.6, 154.5), (149.6, 149.5), 147.2, 140.5,
(135.5, 135.4), 128.5, 128.3, (128.2, 128.1), 119.2, (67.3, 67.2),
(65.6, 65.4), (49.2, 47.8), (45.7, 45.4), (44.0, 43.9), (42.4, 41.9),
(14.3, 14.1); FABMS m/z 532.2 [M + H]+, 530.2 [M - H]-. Anal.
Calcd for C22H25N7O7S‚H2O: C, 48.08; H, 4.91; N, 17.84; S, 5.83.
Found: C, 47.96; H, 4.87; N, 17.65; S, 6.12.
N-[2-(N-Dit h ia su ccin oyl)a m in oet h yl]-N-[[4-N-(b en z-
yloxyca r bon yl)cytosin -1-yl]a cetyl]glycin e (12). Starting
with 7 (80 mg, 0.16 mmol), compound 12 was prepared as
described for compound 11, except the workup and that
heterocyclization with Cl(CdO)SCl (10) (16 µL, 0.19 mmol, 1.2
equiv) was performed at 0 °C. The reaction was complete after
20 min as indicated by HPLC. Next, the solution was distrib-
uted between EtOAc (10 mL) and H2O (15 mL), and the
aqueous phase was extracted with EtOAc (5 × 15 mL). The
combined organic phases were concentrated to a small volume
that upon cooling to -20 °C gave 12 as a white solid (70 mg,
1
84%): mp 198-200 °C; H NMR (DMF-d7) δ (two rotamers)
8.10 (d, J ) 12.0 Hz, 0.4H), 7.91 (d, J ) 12.5 Hz, 0.6H), 7.50-
7.36 (m, 5H), 7.15 (d, J ) 12.0 Hz, 0.4H), 7.14 (d, J ) 12.5 Hz,
0.6H), 5.25 (s, 2H), 4.98 (s, 0.8H), 4.81 (s, 1.2H), 4.41 (s, 1.2H),
4.18 (s, 0.8H), 4.15 (t, J ) 12.0 Hz, 0.8H), 3.98 (t, J ) 9.5 Hz,
1.2H), 3.81 (t, J ) 12.0 Hz, 0.8H), 3.71 (t, J ) 9.5 Hz, 1.2H);
13C NMR (DMF-d7) δ25 (170.9, 170.7), (169.4, 169.2), 168.7,
167.8, (163.8, 163.6), (155.5, 155.3), 153.9, (151.2, 150.9), 136.7,
128.8, 128.5, 128.3, 94.2, 67.1, (49.9, 49.7), (48.7, 48.1), (44.8,
44.5), (43.2, 42.9); FABMS m/z 522.2 [M + H]+, 520.1 [M -
H]-. Anal. Calcd for C20H19N5O8S2: C, 46.06; H, 3.65; N, 13.43;
S, 12.28. Found: C, 45.82; H, 3.90; N, 13.23; S,12.04.
The synthesis of Dts-C(Z)-OH (12) was also carried out at
25 °C with a range of excesses of Cl(CdO)SCl (10) (1-2.2
equiv). HPLC analysis of the crude reaction mixtures showed
12 as the major product, but a significant amount (17-27%)
of 1,2,4-thiadiazolidine-3,5-dione 15 was also detected. Com-
pound 15 was characterized by LC/MS analysis of the crude
mixtures: ESMS (m/z) calcd for C38H38N10O14S 890.3, found
N-[2-(N-Eth oxyth ioca r bon yl)a m in oeth yl]-N-[(th ym in -
1-yl)a cetyl]glycin e (9). Starting with Boc-T-OH (4) (1.15 g,
3 mmol), compound 9 was prepared as described for compound
6, except that less of bis(ethoxythiocarbonyl) sulfide (5) was
used (0.76 g, 3.6 mmol, 1.2 equiv) and the workup was
different. Following overnight stirring, the solution was diluted
with water (50 mL) and washed with CH2Cl2 (2 × 50 mL).
The aqueous phase was acidified to pH 2 with 12 N HCl and
extracted with EtOAc (3 × 80 mL); the phase separations were
890.5 [M + H]+, 446.0 [M + 2H]2+
.
N-[2-(N-Dit h ia su ccin oyl)a m in oet h yl]-N-[[2-N-(b en z-
yloxyca r bon yl) gu a n in -9-yl]a cetyl]glycin e (13). Starting
with 8 (80 mg, 0.15 mmol), compound 13 was prepared as
described above for compound 11, except for workup. The
reaction was complete after 30 min as indicated by HPLC. The
solution was distributed between EtOAc (10 mL) and H2O (15
(25) Each carbon has two resonances, as confirmed by HMQC.